Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 5/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 4/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GFER | P55789 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.34 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24767323 | 0.86 | MEN1 (0.34) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL28098838 | 0.81 | HSD17B10 (0.40) | KMT2APOLBKDM4ETSHRSMN1; SMN2 | |
| SCHEMBL811680 | 0.80 | POLB (0.41) | KMT2AMEN1POLBTSHRSMN1; SMN2 | |
| SCHEMBL5702932 | 0.79 | MEN1 (0.54) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL14486685 | 0.79 | KMT2A (0.42) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL10339638 | 0.77 | KMT2A (0.41) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL29154296 | 0.77 | MEN1 (0.53) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL8464230 | 0.77 | KMT2A (0.53) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL9766076 | 0.77 | TSHR (0.52) | KMT2AMEN1CYP2C9CYP1A2POLB | |
| SCHEMBL28298959 | 0.77 | POLB (0.39) | KMT2AMEN1POLBHTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115043774-B | Synthesis method of fluoroether bacteria amide | 山东省农药检定所 | 2024-07-23 | — | — | CN | disclosed |
| US-20240226255-A9 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2024-07-11 | — | — | US | disclosed |
| US-20240131130-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | UNIV CALIFORNIA (US) | 2024-04-25 | — | — | US | disclosed |
| CN-115015425-B | Method for determining fluoroether bacteria amide residues in red sage root by combining solid phase extraction with UPLC-MS/MS | 山东省农业科学院 | 2024-02-23 | — | — | CN | disclosed |
| CN-115097088-B | Toxicity evaluation method of fluoroether bacteria amide | 山东农业大学 | 2024-02-13 | — | — | CN | disclosed |
| EP-4310504-A2 | ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-01-24 | — | — | EP | disclosed |
| CN-115039783-B | Sterilization composition, preparation method and application thereof | 东莞市东阳光农药研发有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-4294414-A1 | COMPOSITIONS AND METHODS FOR ACTIVATING NK CELLS | The Regents of The University of California (US) | 2023-12-27 | — | — | EP | disclosed |
| EP-3510380-B1 | ACTIVITY-BASED PROBE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE | UNIV LELAND STANFORD JUNIOR (US) | 2023-11-08 | — | — | EP | disclosed |
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-20130338389-A1 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | UT-BATTELLE, LLC (US) | 2013-12-19 | — | — | US | disclosed |
| US-8535560-B2 | Ionic liquids for separation of olefin-paraffin mixtures | UT-BATTELLE, LLC (US) | 2013-09-17 | — | — | US | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| WO-2011008664-A2 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | UT-BATTELLE, LLC (US) | 2011-01-20 | — | — | WO | disclosed |
| US-20110015461-A1 | Ionic Liquids for Separation of Olefin-Paraffin Mixtures | UT-BATTELLE, LLC (US) | 2011-01-20 | — | — | US | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |
| US-5360819-A | Nonradioactive labels which provide a ketone signal, vapor phase analysis | NORTHEASTERN UNIVERSITY (US) | 1994-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130338389-A1 | IONIC LIQUIDS FOR SEPARATION OF OLEFIN-PARAFFIN MIXTURES | POU2F1, POU2F2, POF1B | KMT2A 3578/4885MEN1 1717/4885CYP2C9 2348/4885 |
| US-20110015461-A1 | Ionic Liquids for Separation of Olefin-Paraffin Mixtures | POU2F1, POU2F2, POF1B | KMT2A 3578/4885MEN1 1717/4885CYP2C9 2348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.